February 1st, 1986. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody
MAb B72. 3 thus appears to be an appropriate diagnostic adjunct capable of discriminating between these malignancies.
